KPDS demands gov. action to end chemotherapy drug shortages
By Kang, Hye-Kyung | translator Kim, Jung-Ju
23.12.28 13:09:31
가나다라
0
The KPDS urges gov. to release information on corrective measures to address 5-FU drug shortages.
“Government should take responsible measures to instill trust in citizens that essential medicines taken today will continue to be available in the future.”
▲The Korean Pharmacists for Democratic Society (KPDS)
The Korean Pharmacists for Democratic Society (CEO: Hyeong-geun Shin, KPDS) has criticized the government’s system for the stable supply of essential medicines.
The KPDS stated on the 28th that “5-fluorouracil, referred to as 5-FU, is a chemotherapy drug used to treat several types of cancers, including colorectal cancer, esophageal cancer, pancreatic cancer, and breast cancer. It is considered essential for treatments that it has been listed in the WHO’s list of essential medicines, and in Korea, it has been designated and managed as a shortage prevention drug (SPD) since 2010. However, over the past month, the unstable supply and demand of 5-FU have led to delays in chemotherapy schedules,
Kang, Hye-Kyung(khk@dailypharm.com )
If you want to see the full article, please JOIN US (click)